Molecular anatomy of mouse hepatitis virus persistence: Coevolution of increased host cell resistance and virus virulence

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3947-3960

  Chen, Wan ^a   Baric, Ralph S ^a,b  

^a IL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; ASTROCYTOMA CELL; CANCER CELL CULTURE; HEPATITIS VIRUS; HOST RESISTANCE; INFECTION RESISTANCE; MOUSE; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VIRUS DNA CELL DNA INTERACTION; VIRUS EXPRESSION; VIRUS INFECTIVITY; VIRUS REPLICATION;

EID: 0030023675     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3947-3960.1996     Document Type: Article

References (70)

1. Ahmed, R., C. S. Hahn, T. Somasundaram, L. Villarette, M. Matloubian, and J. H. Strauss. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:4242-4247.
2. Ahmed, R., and J. G. Stevens. 1990. Viral persistence, p. 241-265. In B. N. Fields and D. M. Knipe (ed.), Virology. Raven Press, New York.
3. Apple, R. J., H. A. Erlich, W. Klitz, M. M. Manos, T. M. Becker, and C. M. Wheeler. 1994. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature Genet. 6:157-162.
4. Baybutt, H. N., H. Wege, M. J. Carter, and V. Ter Meulen. 1984. Adaptation of coronavirus JHM to persistent infection of murine Sac(-) cells. J. Gen. Virol. 65:915-924.
5. Black, F. L. 1992. Why did they die? Science 258:1739-1740.
6. Borzakian, S., T. Couderc, Y. Barbier, G. Attal, I. Pelletier, and F. Colbere-Garapin. 1992. Persistent poliovirus infection: infection establishment and maintenance involve distinct mechanisms. Virology 186:398-408.
7. Borzakian, S., I. Pelletier, V. Calvez, and F. Colbere-Garapin. 1993. Precise missense and silent point mutations are fixed in the genomes of poliovirus mutants from persistently infected cells. J. Virol. 67:2914-2917.
8. Boyle, J. F., D. G. Weismiller, and K. V. Holmes. 1987. Genetic resistance to mouse hepatitis virus correlates with absence of virus-binding activity on target tissues. J. Virol. 61:185-189.
9. Burks, J. S., B. L. Devald, L. D. Jakovsky, and J. C. Gerdes. 1980. Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 209:933-934.
10. Chen, W., and R. S. Baric. 1995. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:7529-7540.
11. Compton, S. R. 1994. Enterotropic strains of mouse coronavirus differ in their use of murine carcinoembryonic antigen-related glycoprotein receptors. Virology 203:197-201.
12. de la Torre, J. C., E. Martinez-Salas, J. Diez, A. Villaverde, F. Gebauer, E. Rocha, M. Dávila, and E. Domingo. 1988. Coevolution of cells and viruses in a persistent infection of foot-and-mouth disease virus in cell culture. J. Virol. 62:2050-2058.
13. Delmas, B., J. Gelfi, R. L'Haridon, L. K. Vogel, H. Sjostrom, O. Noren, and H. Laude. 1992. Aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. Nature (London) 357:417-420.
14. Derraody, T. S., J. D. Chappell, J. G. Hofler, W. Kramp, and K. L. Tyler. 1995. Eradication of persistent reovirus infection from a B-cell hyhridoma. Virology 212:272-276.
15. Dermody, T. S., M. L. Nibert, D. Wetzel, X. Tong, and B. N. Fields. 1993. Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J. Virol. 67:2055-2063.
16. Dveksler, G. S., A. A. Basile, C. B. Cardellichio, and K. V. Holmes. 1995. Mouse hepatitis virus receptor activities of an MHVR/mph chimera and MHVR mutants lacking N-linked glycosylation of the N-terminal domain. J. Virol. 69:543-546.
17. Dveksler, G. S., C. W. Dieffenbach, C. B. Cardellichio, K. McCuaig, M. N. Pensiero, G.-S. Jiang, N. Beauchemin, and K. V. Holmes. 1993. Several members of the mouse carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus-A59. J. Virol. 67:1-8.
18. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G.-S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
19. Dveksler, G. S., M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A. A. Basile, P. E. Ella, and K. V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
20. Ewald, P. W. 1993. The evolution of virulence. Sci. Am. 4:86-93.
21. Fantini, J., D. G. Cook, N. Nathanson, S. L. Spitalnik, and F. Gonzalez-Scarano. 1993. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. USA 90:2700-2704.
22. Fenner, F., and P. J. Kerr. 1994. Evolution of the poxviruses, including the coevolution of virus and host in myxomatosis, p. 273-292. In S. S. Morse (ed.), The evolutionary biology of viruses. Raven Press, Ltd., New York.
23. Fleming, J. O., J. J. Houtman, H. Alaca, H. C. Hinze, D. McKenzie, J. Aiken, T. Bleasdale, and S. Baker. 1994. Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4, p. 327-332. In H. Laude and F. J. Vautherot (ed.), Coronaviruses. Plenum Press, New York.
24. Friedman, M. J. 1978. Erythrocytic mechanism of sickle-cell resistance to malaria. Proc. Natl. Acad. Sci. USA 75:1994-1997.
25. Gabriel, S. E., K. N. Brigman, B. H. Koller, R. C. Boucher, and M. J. Stutts. 1994. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model. Science 266:107-109.
26. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
27. Gombold, J. L., S. T. Thingley, and S. R. Weiss. 1993. Fusion-negative mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
28. Hingley, S. T., J. L. Gombold, E. Lavi, and S. R. Weiss. 1994. MHV-A59 fusion mutants are attenuated and display altered hepatotropism. Virology 200:1-10.
29. Hirano, N., K. Fujiwara, S. Hino, and M. Matumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
30. Hirano, N., N. Goto, S. Makino, and K. Fujiwara. 1981. Persistent infection with mouse hepatitis virus JHM strain in DBT cell culture, p. 301-308. In V. ter Meulen, S. Siddell, and H. Wege (ed.), Biochemistry and biology of coronaviruses. Plenum Press, New York.
31. Hofmann, M. A., R.-Y. Chang, S. Ku, and D. A. Brian. 1993. Leader-mRNA junction sequences are unique for each subgenomic mRNA species in the bovine coronavirus and remain so throughout persistent infection. Virology 196:163-171.
32. Hofmann, M. A., S. D. Senanayake, and D. A. Brian. 1993. A translationattenuating intraleader open reading frame is selected on curonavirus mRNAs during persistent infection. Proc. Natl. Acad. Sci. USA 90:11733-11737.
33. Hofmann, M. A., P. B. Sethna, and D. A. Brian. 1990. Bovine coronavirus mRNA replication continues throughout persistent infection in cell culture. J. Virol. 64:4108-4114.
34. Holmes, K. V., and J. N. Behnke. 1981. Evolution of a coronavirus during persistent infection in vitro, p. 287-299. In V. ter Meulen, S. Siddell, and H. Wege (ed.), Biochemistry and biology of coronaviruses. Plenum Press, New York.
35. Johnson, R. B. 1986. Human disease and the evolution of pathogen virulence. J. Theor. Biol. 122:19-24.
36. Kilbourne, E. D. 1994. Host determination of virus evolution: a variable tautology, p. 253-271. In S. S. Morse (ed.), The evolutionary biology of viruses. Raven Press, Ltd., New York.
37. Knobler, R. L., P. W. Lampert, and M. B. A. Oldstone. 1982. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature (London) 298:279-280.
38. Kumanishi, T. 1967. Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. 1. Introduction of brain tumors in adult mice with Rous chicken sarcoma cells. Jpn. J. Exp. Med. 37:461-474.
39. Many, B. W. J. 1985. Strategies of viral persistence. Br. Med. Bull. 41:50-55.
40. Malo, D., and E. Skamene. 1994. Genetic control of host resistance to infection. Trends Genet. 10:365-371.
41. Martin Hernandez, A. M., E. C. Carrillo, N. Sevilla, and E. Domingo. 1994. Rapid cell variation can determine the establishment of a persistent viral infection. Proc. Natl. Acad. Sci. USA 91:3705-3709.
42. McCuaig, K., M. Rosenberg, P. Nedellec, C. Turbide, and N. Beauchemin. 1993. Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. Gene 127:173-183.
43. Mizzen, L., S. Cheley, M. Rao, R. Wolf, and R. Andersen. 1983. Fusion resistance and decreased infcctahility as major host cell determinants of coronavirus persistence. Virology 128:407-417.
44. Murray, R. S., G.-Y. Cai, K. Hoel, J.-Y. Zhang, K. F. Soike, and G. F. Cabirac. 1992. Coronavirus infects and causes demyelination in primate central nervous system. Virology 188:274-284.
45. Nedellec, P., G. S. Dveksler, E. Daniels, C. Turbide, B. Chow, A. A. Basile, K. V. Holmes, and N. Beauchemin. 1994. Bgp2, a new member of the carcinoembryonic antigen-related gene family, encodes an alternative receptor for mouse hepatitis viruses. J. Virol. 68:4525-4537.
46. Nicolson, G. L. 1987. Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. Cancer Res. 47:1473-1487.
47. Pachuk, C., P. J. Bredenbeek, P. W. Zoltick, W. J. M. Spaan, and S. R. Weiss. 1989. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis coronavirus, strain A59. Virology 171:141-148.
48. Pavlovic, J., O. Haller, and P. Staeheli. 1992. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol. 66:2564-2569.
49. Perlman, S., G. Jacobsen, L. A. Olson, and A. Afifi. 1990. Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus. Virology 175:418-426.
50. Ron, D., and J. Tal. 1985. Coevolution of cells and virus as a mechanism for the persistence of lymphotropic minute virus of mice in L cells. J. Virol. 55:424-430.
51. Rosner, B. 1990. Fundamentals of biostatistics, p. 336-342. PWS-KENT Publishing Co., Boston.
52. Rudert, F., A. M. Saunders, S. Rebstock, J. A. Thompson, and W. Zimmer-mann. 1992. Characterization of murine carcinoembryonic antigen gene family members. Mamm. Genome 3:262-273.
53. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 14.2-14.4. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
54. Sawcki, S. G., J.-H. Lu, and K. V. Holmes. 1995. Persistent infection of cultured cells with mouse hepatitis virus (MHV) results from the epigenetic expression of the MHV receptor. J, Virol. 69:5535-5543.
55. Schaad, M. C., and R. S. Baric. 1993. Evidence for new transcriptional units encoded at the 3′ end of the mouse hepatitis virus genome. Virology 196:190-198.
56. Schaad, M. C., S. A. Stohlman, J. Egbert, K. Lum, K.-S. Fu, T. J. Wei, and R. S. Baric. 1990. Genetics of mouse hepatitis virus transcription: identification of cistrons which may function in positive and negative strand RNA synthesis. Virology 177:634-645.
57. Shively, J. E., and J. D. Beatty. 1985. CEA-related antigens: molecular biology and clinical significance. Crit. Rev. Oncol. Hematol. 2:355-399.
58. Skamene, E. 1991. Population and molecular genetics of susceptibility to tuberculosis. Clin. Invest. Med. 14:160-166.
59. Stead, W. W. 1992. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann. Intern. Med. 116:937-941.
60. Stohlman, S. A., A. Y. Sakaguchi, and L. P. Weiner. 1979. Characterization of the cold-sensitive hepatitis virus mutants rescued from latently infected cells by cell fusion. Virology 98:448-455.
61. Stohlman, S. A., A. Y. Sakaguchi, and L. P. Weiner. 1979. Rescue of a positive-stranded RNA virus from antigen-negative neuroblastoma cells. Life Sci. 24:1029-1036.
62. Stohlman, S. A., and L. P. Weiner. 1978. Stability of neurotropic mouse hepatitis virus (JHM) strain during chronic infection of neuroblastoma cells. Arch. Virol. 57:53-61.
63. Thompson, J. A., F. Grunert, and W. Zintmermann. 1991. The carcinoembryonic antigen gene family: molecular biology and clinical perspectives. J. Clin. Lab. Anal. 5:63-83.
64. Vlasak, R., W. Luytjes, W. J. M. Spaan, and P. Palese. 1988. Human and bovine coronaviruses recognize sialic acid-containing receptor similar to those of influenza C virus. Proc. Natl. Acad. Sci. USA 85:4526-4529.
65. Wang, K.-S., R. J. Kuhn, E. G. Strauss, S. Ou, and J. H. Strauss. 1992. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66:4992-5001.
66. Weiss, R. A. 1993. Cellular receptors and viral glycoproteins involved in retrovirus entry, p. 1-108. In J. A. Levy (ed.), The Retroviridae. Plenum Press, New York.
67. Williams, R. K., G.-S. Jiang, S. W. Snyder, M. F. Frana, and K. V. Holmes. 1990. Purification of the 110-kilodalton glycoprotcin receptor for mouse hepatitis virus (MHV)-A59 from mouse liver and identification of a non-functional, homologous protein in MHV-resistant SJL/J mice. J. Virol. 64:3817-3823.
68. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature (London) 357:420-422.
69. Yokomori, K., M. Asanaka, S. A. Stohlman, and M. M. C. Lai. 1993. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry. Virology 196:45-56.
70. Yokomori, K., and M. M. C. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:6194-6199.